2018
DOI: 10.1515/sjpain-2018-0012
|View full text |Cite
|
Sign up to set email alerts
|

The validity of pain intensity measures: what do the NRS, VAS, VRS, and FPS-R measure?

Abstract: Abstract Background and aims: The Numerical Rating Scale (NRS), Visual Analogue Scale (VAS), Verbal Rating Scale (VRS), and Faces Pain Scale-Revised (FPS-R) are valid measures of pain intensity. However, ratings on these measures may be influenced by factors other than pain intensity. The purpose of this study was to evaluate the influence of non-pain intensity factors on the pain intensity s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

9
327
0
16

Year Published

2018
2018
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 436 publications
(352 citation statements)
references
References 49 publications
9
327
0
16
Order By: Relevance
“…PGA is an instrument which measures the patient's global assessment of his or her own disease activity. Patients were asked “What's your assessment of your disease activity during the last week?” and had to rate 0‐10 on a visual analog scale, where higher scores indicate poorer global assessment . While both CRP and erythrocyte sedimentation rate can be used as the laboratory marker component in calculating the overall ASDAS score, we used CRP as previous studies have demonstrated that CRP was associated with disease activity in patients with axSpA .…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…PGA is an instrument which measures the patient's global assessment of his or her own disease activity. Patients were asked “What's your assessment of your disease activity during the last week?” and had to rate 0‐10 on a visual analog scale, where higher scores indicate poorer global assessment . While both CRP and erythrocyte sedimentation rate can be used as the laboratory marker component in calculating the overall ASDAS score, we used CRP as previous studies have demonstrated that CRP was associated with disease activity in patients with axSpA .…”
Section: Methodsmentioning
confidence: 99%
“…BASFI (range 0‐10) is a disease‐specific instrument measuring function with higher values indicating poorer physical functioning . BASG and Pain scores were also collected (range 0‐100), where higher scores reflect poorer well‐being and higher pain, respectively …”
Section: Methodsmentioning
confidence: 99%
“…BASFI (ranges from 0 to 10) is a disease‐specific instrument to measure function, with higher values indicating worse functioning . Pain (ranges from 0 to 10) and PGA (ranges from 0 to 10) reflect poorer functioning and greater pain with higher scores …”
Section: Methodsmentioning
confidence: 99%
“…20 Pain (ranges from 0 to 10) and PGA (ranges from 0 to 10) reflect poorer functioning and greater pain with higher scores. 21 HAQ-DI (ranges from 0 to 3) is an instrument to measure disability and it has been validated among patients with SpA in Singapore. 22 Higher scores reflect worse disability.…”
Section: Comparison Instrumentsmentioning
confidence: 99%
“…Primary outcome measures were the self‐report of pain intensity using a VAS (Bijur, Silver, & Gallagher, ; Kersten, White, & Tennant, ; Thong, Jensen, Miro, & Tan, ; Wewers & Lowe, ) and function using the Timed Up and Go (TUG; Evensen, Kvåle, & Braekken, , ), which have been reported to be valid and reliable measures. Each participant was instructed to score their pain intensity on a VAS from a 0 ( no pain ) to 10 ( worst possible pain ) point scale, anchored by word descriptors (Wewers & Lowe, ).…”
Section: Methodsmentioning
confidence: 99%